Functional Nanomaterials for Drug Delivery and Pharmaceutical Applications

Dear Colleagues,

Over the past decades, the development of novel functional nanomaterials for biomedical applications has attracted much attention. Nanomaterials can be composed of nanostructures such as nanoparticles, nanocapsules, nanotubes, and nanosheets. Due to their nanoscale size, nanomaterials can move easily in tissues and cells and are considered to be an emerging and promising drug delivery system.

Typical nano-based delivery vehicles include liposomes, micelles, dendrimers, inorganic vectors, nanogels and nanoemulsions, whereas novel nanocarriers also contain biomimetic reconstituted high-density lipoproteins (rHDL), exosomes, and hybrid nanoparticles that come from the mixture of nanomaterials. Furthermore, as important constituents of nano-based drug delivery systems, various nanomaterials such as organic nanomaterials, inorganic nanomaterials, and hybrid nanomaterials have been intensively explored in pharmaceutical fields, including drug formulation, drug/gene delivery, controlled release, and targeted therapy.

In this Special Issue, we aim to collect submissions that focus on the investigation of “Functional Nanomaterials for Drug Delivery and Pharmaceutical Applications”. Original research articles and reviews are welcome. We also encourage the submission of papers including in vitro and in vivo evidence and clinical data on nanomedicine and nanotechnology fields.

We look forward to receiving your contributions.

Prof. Dr. Wei Wang
Prof. Dr. Cong Luo
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.